Curcumin protects organotypic hippocampal slice cultures from Aβ1-42-induced synaptic toxicity

Toxicology in Vitro

Volumn 27, Issue 8, 2013, Pages 2325-2330

  Hoppe, Juliana Bender ^a,b   Haag, Marcus ^a   Whalley, Benjamin Jason ^a   Salbego, Christianne Gazzana ^b   Cimarosti, Helena ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Beta amyloid peptide; CaMKII; Curcumin; Multi electrode array; Organotypic hippocampal slice culture; Synapsin I

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CURCUMIN; SYNAPSIN I;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; ELECTRIC POTENTIAL; HIPPOCAMPUS; NERVE CELL NECROSIS; NERVE CONDUCTION; NERVE EXCITABILITY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN PHOSPHORYLATION; RAT; SYNAPTIC TOXICITY; SYNAPTIC TRANSMISSION;

BETA-AMYLOID PEPTIDE; CAMKII; CURCUMIN; MULTI-ELECTRODE ARRAY; ORGANOTYPIC HIPPOCAMPAL SLICE CULTURE; SYNAPSIN I;

AMYLOID BETA-PEPTIDES; ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CURCUMIN; HIPPOCAMPUS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; SYNAPSES; SYNAPSINS;

EID: 84887333173     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2013.10.002     Document Type: Article

References (47)

1. 2+/calmodulin-dependent protein kinase II. Brain Res. Mol. Brain Res. 1996, 40:297-309.
2. Chi P., Greengard P., Ryan T.A. Synaptic vesicle mobilization is regulated by distinct synapsin I phosphorylation pathways at different frequencies. Neuron 2003, 38:69-78.
3. Cimarosti H., Kantamneni S., Henley J.M. Ischaemia differentially regulates GABA(B) receptor subunits in organotypic hippocampal slice cultures. Neuropharmacology 2009, 56:1088-1096.
4. Coleman P., Federoff H., Kurlan R. A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology 2004, 63:1155-1162.
5. Corona C., Pensalfini A., Frazzini V., Sensi S.L. New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc. Cell Death Dis. 2011, 2:e176.
6. Decker H., Jürgensen S., Adrover M.F., Brito-Moreira J., Bomfim T.R., Klein W.L., Epstein A.L., De Felice F.G., Jerusalinsky D., Ferreira S.T. N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers. J. Neurochem. 2010, 115:1520-1529.
7. Evans N.A., Facci L., Owen D.E., Soden P.E., Burbidge S.A., Prinjha R.K., Richardson J.C., Skaper S.D. A beta(1-42) reduces synapse number and inhibits neurite outgrowth in primary cortical and hippocampal neurons: a quantitative analysis. J. Neurosci. Methods 2008, 175:96-103.
8. Hartley D.M., Walsh D.M., Ye C.P., Diehl T., Vasquez S., Vassilev P.M., Teplow D.B., Selkoe D.J. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 1999, 19:8876-8884.
9. Hilfiker S., Pieribone V.A., Czernik A.J., Kao H.T., Augustine G.J., Greengard P. Synapsins as regulators of neurotransmitter release. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 1999, 354:269-279.
10. Hill A.J., Jones N.A., Williams C.M., Stephens G.J., Whalley B.J. Development of multi-electrode array screening for anticonvulsants in acute rat brain slices. J. Neurosci. Methods 2010, 185:246-256.
11. Holopainen I.E., Lauren H.B. Neuronal activity regulates GABAA receptor subunit expression in organotypic hippocampal slice cultures. Neuroscience 2003, 118:967-974.
12. Hoppe J.B., Frozza R.L., Horn A.P., Comiran R.A., Bernardi A., Campos M.M., Battastini A.M., Salbego C. Amyloid-beta neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK-3beta, tau and neuroinflammation. J. Pineal Res. 2010, 48:230-238.
13. Hoppe J.B., Coradini K., Frozza R.L., Oliveira C.M., Meneghetti A.B., Bernardi A., Pires E.S., Beck R.C., Salbego C.G. Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3β signaling pathway. Neurobiol. Learn. Mem. 2013, 106:134-144.
14. Ishige K., Takagi N., Imai T., Rausch W.D., Kosuge Y., Kihara T., Kusama-Eguchi K., Ikeda H., Cools A.R., Waddington J.L., Koshikawa N., Ito Y. Role of caspase-12 in amyloid beta-peptide-induced toxicity in organotypic hippocampal slices cultured for long periods. J. Pharmacol. Sci. 2007, 104:46-55.
15. Ishrat T., Hoda M.N., Khan M.B., Yousuf S., Ahmad M., Khan M.M., Ahmad A., Islam F. Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT). Eur. Neuropsychopharmacol. 2009, 19:636-647.
16. Jo J., Whitcomb D.J., Olsen K.M., Kerrigan T.L., Lo S.C., Bru-Mercier G., Dickinson B., Scullion S., Sheng M., Collingridge G., Cho K. A beta(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3beta. Nat. Neurosci. 2011, 14:545-547.
17. Kamenetz F., Tomita T., Hsieh H., Seabrook G., Borchelt D., Iwatsubo T., Sisodia S., Malinow R. APP processing and synaptic function. Neuron 2003, 37:925-937.
18. Koffie R.M., Meyer-Luehmann M., Hashimoto T., Adams K.W., Mielke M.L., Garcia-Alloza M., Micheva K.D., Smith S.J., Kim M.L., Lee V.M., Hyman B.T., Spires-Jones T.L. Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc. Natl. Acad. Sci. USA 2009, 106:4012-4017.
19. Koffie R.M., Hyman B.T., Spires-Jones T.L. Alzheimer's disease: synapses gone cold. Mol. Neurodegener. 2011, 6:63.
20. Ma T., Klann E. Amyloid beta: linking synaptic plasticity failure to memory disruption in Alzheimer's disease. J. Neurochem. 2012, 120:140-148.
21. Ma Q.L., Zuo X., Yang F., Ubeda O.J., Gant D.J., Alaverdyan M., Teng E., Hu S., Chen P.P., Maiti P., Teter B., Cole G.M., Frautschy S.A. Curcumin suppresses soluble tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits in aged human tau transgenic mice. J. Biol. Chem. 2013, 288:4056-4065.
22. Masliah E., Mallory M., Alford M., DeTeresa R., Hansen L.A., McKeel D.W., Morris J.C. Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology 2001, 56:127-129.
23. Mitra P., Bokil H. Observed Brain Dynamics 2007, Oxford University Press, p. 408.
24. Ninan I., Arancio O. Presynaptic CaMKII is necessary for synaptic plasticity in cultured hippocampal neurons. Neuron 2004, 42:129-141.
25. Noraberg J., Poulsen F.R., Blaabjerg M., Kristensen B.W., Bonde C., Montero M., Meyer M., Gramsbergen J.B., Zimmer J. Organotypic hippocampal slice cultures for studies of brain damage, neuroprotection and neurorepair. Curr. Drug Targets CNS Neurol. Disord. 2005, 4:435-452.
26. Palop J.J., Mucke L. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat. Neurosci. 2010, 13:812-818.
27. Pi H.J., Otmakhovm N., El Gaamouch F., Lemelin D., De Koninck P., Lisman J. CaMKII control of spine size and synaptic strength: role of phosphorylation states and nonenzymatic action. Proc. Natl. Acad. Sci. USA 2010, 107:14437-14442.
28. Qin S., Hu X.Y., Xu H., Zhou J.N. Regional alteration of synapsin I in the hippocampal formation of Alzheimer's disease patients. Acta Neuropathol. 2004, 107:209-215.
29. Qin X.Y., Cheng Y., Yu L.C. Potential protection of curcumin against intracellular amyloid beta-induced toxicity in cultured rat prefrontal cortical neurons. Neurosci. Lett. 2010, 480:21-24.
30. (2+)/calmodulin-dependent protein kinase II-alpha in the hippocampus of subjects with mild cognitive impairment and Alzheimer's disease. J. Neurochem. 2011, 119:791-804.
31. Sanhueza M., Lisman J. The CaMKII/NMDAR complex as a molecular memory. Mol. Brain 2013, 6:10.
32. Selkoe D.J. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav. Brain Res. 2008, 192:106-113.
33. Shankar G.M., Walsh D.M. Alzheimer's disease: synaptic dysfunction and A beta. Mol. Neurodegener. 2009, 4:48.
34. Shankar G.M., Bloodgood B.L., Townsend M., Walsh D.M., Selkoe D.J., Sabatini B.L. Natural oligomers of the Alzheimer amyloid beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J. Neurosci. 2007, 27:2866-2875.
35. Suh E.C., Jung Y.J., Kim Y.A., Park E.M., Lee K.E. A beta 25-35 induces presynaptic changes in organotypic hippocampal slice cultures. Neurotoxicology 2008, 29:691-699.
36. Sun C.Y., Qi S.S., Zhou P., Cui H.R., Chen S.X., Dai K.Y., Tang M.L. Neurobiological and pharmacological validity of curcumin in ameliorating memory performance of senescence-accelerated mice. Pharmacol. Biochem. Behav. 2013, 105C:76-82.
37. Tanzi R.E., Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 2005, 120:545-555.
38. Tsai J., Grutzendler J., Duff K., Gan W.B. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat. Neurosci. 2004, 7:1181-1183.
39. Varghese K., Molnar P., Das M., Bhargava N., Lambert S., Kindy M.S., Hickman J.J. A new target for amyloid beta toxicity validated by standard and high-throughput electrophysiology. PLoS One 2010, 5:e8643.
40. Wu A., Ying Z., Gomez-Pinilla F. Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition. Exp. Neurol. 2006, 197:309-317.
41. Wu A., Ying Z., Schubert D., Gomez-Pinilla F. Brain and spinal cord interaction: a dietary curcumin derivative counteracts locomotor and cognitive deficits after brain trauma. Neurorehabil. Neural Repair 2011, 25:332-342.
42. Xie C.W. Calcium-regulatedsignalingpathways: role in amyloid beta-induced synaptic dysfunction. Neuromolecular Med. 2004, 6:53-64.
43. Xu Y., Lin D., Li G., Shyamala S.G., Barish P.A., Vernon M.M., Pan J., Ogle W.O. Curcumin reverses impaired cognition and neuronal plasticity induced by chronic stress. Neuropharmacology 2009, 57:463-471.
44. Yamagata Y. New aspects of neurotransmitter release and exocytosis: dynamic and differential regulation of synapsin I phosphorylation by acute neuronal excitation in vivo. J. Pharmacol. Sci. 2003, 93:22-29.
45. Ye J., Zhang Y. Curcumin protects against intracellular amyloid toxicity in rat primary neurons. Int. J. Clin. Exp. Med. 2012, 5:44-49.
46. Zeng Y., Zhao D., Xie C.W. Neurotrophins enhance CaMKII activity and rescue amyloid-beta-induced deficits in hippocampal synaptic plasticity. J. Alzheimers Dis. 2010, 21:823-831.
47. Zhao D., Watson J.B., Xie C.W. Amyloid beta prevents activation of calcium/calmodulin-dependent protein kinase II and AMPA receptor phosphorylation during hippocampal long-term potentiation. J. Neurophysiol. 2004, 92:2853-2858.